The U.S. Drug Enforcement Administration (DEA) has finalized a long-awaited rule that formally explains how EMS agencies may legally obtain, store, carry, administer, and restock controlled medications such as fentanyl, morphine, ketamine, and benzodiazepines.

This rule implements the Protecting Patient Access to Emergency Medications Act of 2017 (PPAEMA) and replaces years of inconsistent or unclear federal guidance.

Importantly, the rule is in effect as of March 9, 2026. This article explains the rule in plain English and outlines what EMS agencies should already be doing.

While many things about the rule will not change how EMS operates, there are several steps that must be taken to comply, most specifically registering as an independent entity with the DEA.

• If you are a hospital owned provider, you can continue operating exactly as you have been, however a thorough review of controlled substance storage and recordkeeping procedures would be highly recommended.
• If you are a municipal or government owned (not contracted) entity, you do have to go through the registration process, but you should be exempted from the $888 fee. (Registration is for 3 years)
• If you are any other category of EMS entity, you must complete the registration and pay the 3-year registration fee.

---

Why all of this is important

For years, EMS agencies have relied on:

• A medical control agreement and the medical director’s DEA license
• A hospital’s DEA license for stocking and issuance of kits
• Informal local interpretations of federal law

The new rule does not eliminate EMS access to controlled medications. Instead, it clearly defines legal pathways and expectations so EMS agencies can operate safely, legally, and consistently nationwide.

If your agency carries or administers controlled substances, this rule applies to you.

---

Let’s look at the big picture … what’s really changed?

1. EMS agencies are now officially recognized by DEA

The DEA has created a specific registration category for EMS agencies. That means:

• EMS agencies can (must in most cases) hold their own DEA registration
• One registration can cover an entire state
• EMS is no longer treated as a “gray area” under physician or hospital licenses

2. EMS can still use standing orders and verbal orders

Nothing changes clinically. EMS professionals may continue to administer controlled substances under standing orders approved by a medical director or under verbal orders from an authorized practitioner. The medical director does not need to be physically present.

The rule also does not change any laws in effect in your state or jurisdiction. The DEA rule sets the federal floor, not the ceiling.

3. Storage and vehicle rules are now explicit

Controlled substances may be stored:

• At a DEA-registered EMS location
• At an approved stationhouse / designated location
• In an EMS vehicle that is actively in service

There is no specific type of box required – keyed, combination or electronic fob access types are all acceptable. No matter which physical infrastructure you use, the important consideration is to have a clearly defined system and policy, that allows you to maintain and clearly document the chain of custody for every dose of medication.

Important clarification: A locked ambulance alone is not enough. Controlled substances in vehicles must be kept in separately locked safe or cabinet that is permanently mounted and not easily removed. They may be carried on a provider’s person only when actively responding to a call. When a unit is unattended and not actively responding, medications must be secured appropriately. They must be secured outside the unit if it is out of service.

4. Stationhouses can store medications (with notice)

EMS agencies may designate legitimate EMS bases/stationhouses as approved storage locations for controlled substances, but must notify DEA at least 30 days before medications are delivered.

This is critical for rural and multi-station agencies, as it allows medications to be stored at strategically placed bases within your response area.

5. Restocking rules are clearer and more flexible

EMS agencies may:

• Restock controlled substances at hospitals
• Restock at more than one hospital
• Do so without DEA Form 222, if recordkeeping requirements are met

The rule confirms that restocking is not limited to a single “home” hospital.

6. Recordkeeping is required, but practical

Agencies must keep records of:

• Receipt of medications
• Administration to patients
• Transfers between agency locations
• Loss, theft, or disposal

Records must simply identify who authorized and who administered the medication and must be retained for at least two years. There is no requirement that a medical director initial every dose.

---

Registration pathways for EMS agencies

Many EMS agencies operating under a medical director’s personal DEA registration will need to re-assess under the new rule. The DEA now expects that each agency will transition to its own registration – continuing under a legacy model risks non-compliance.

There are two primary ways that an EMS agency can register with the DEA. Each agency should identify which pathway it is using as soon as possible.

Option 1: EMS agency holds its own DEA registration

Recommended for many non-hospital EMS agencies

• Apply for a DEA EMS Agency registration (one per state)
• Agency directly receives, stores, and manages medications
• Medical director authorizes use through protocols

Option 2: Hospital-based EMS uses the hospital’s DEA registration

Works best for fully integrated hospital EMS programs.

• Still allowed under the rule
• Requires clear agreements and alignment with hospital compliance

---

What EMS agencies should do next (checklist)

Step 1: Decide your registration pathway

Ask:

• Are we agency-registered, hospital-based, or physician-dependent?
• Does our current model still meet federal requirements?

Step 2: Inventory where medications are stored

Document:

• Stations
• Vehicles
• Lockers
• Jump bags
• Hospitals used for restocking

Identify which locations need to be:

• Registered
• Designated (30-day notice)
• Equipped with additional security measures/devices

Step 3: Submit stationhouse designations early

If you use stations for storage:

• Submit DEA designation at least 30 days before delivery
• Do not wait! This rule is currently in effect, and you are subject to enforcement actions for non-compliance.

Step 4: Verify vehicle safes and security

Confirm that every unit has a separately locked medication safe and meets DEA expectations for unattended vehicles. This is a common inspection failure point.

Step 5: Review documentation and diversion logs

Ensure that

• PCRs and medication logs identify authorization and administration
• Transfers between locations are tracked
• Records are retained for 2 years

Avoid over-engineering the signatures required on this documentation, such as another licensed provider attesting to the transfer of a medication. DEA explicitly discouraged that.

Step 6: Educate leadership and crews

Every provider should understand:

• When medications may be carried on their person
• When they must be returned to compliant storage
• What to do after restocking or transfers

Note: We recommend a short MANDATORY training class outlining any changes to your program. Keep the attendance records for at least two years.

---

Timeline to remember

• February 5, 2026 – Rule published
• March 9, 2026 – Rule took effect
• 30 days prior – Required notice for stationhouse designations

---

Bottom line

This rule clarifies controlled substance management and storage requirements and requires every agency to re-assess their compliance with the new regulations. Need help or an outside review of your program? Reach out and talk to us anytime.